The Digital health committee recently shared its position paper, Harnessing the potential of digital health technologies – Policy Pathways for Value Assessment & Reimbursement, aiming at leading toward the creation of a fit-for-purpose framework for Digital Health.
During this webinar, Chris L. Hardesty, Director, Healthcare & Life Sciences Practice at KPMG, moderated a panel discussion with Anh Bourcet, Director ASPAC Health Economics & Market Access, Health Outcomes, Global Orthopedics & Biosurgery at Johnson & Johnson, and Arif Fahim, Regional Director – Asia Pacific, Global Health Economics & Reimbursement at Abbott.
The Paper is available on our website: LINK
